Platelet activation in heart transplant recipients

Clinical Transplantation

Volumn 18, Issue 2, 2004, Pages 142-147

  Hognestad, Aina ^a   Michelsen, Annika ^a   Brosstad, Frank ^a   Damås, Jan K ^a   Holm, Torbjørn ^a   Simonsen, Svein ^a   Kjekshus, John K ^a   Aukrust, Pål ^a   Andreassen, Arne K ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

Heart transplantation; Platelet activation

Indexed keywords

ACETYLSALICYLIC ACID; AZATHIOPRINE; CD40 LIGAND; CD63 ANTIGEN; CYCLOSPORIN; CYTOKINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PADGEM PROTEIN; PREDNISONE; THROMBIN RECEPTOR ACTIVATING PEPTIDE;

ADULT; AGED; ARTICLE; CELL STIMULATION; COMORBIDITY; CONTROLLED STUDY; ENZYME IMMUNOASSAY; EXPERIMENTATION; FEMALE; FLOW CYTOMETRY; GRAFT REJECTION; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; HUMAN CELL; HYPERTENSION; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECIPIENT; SURVIVAL TIME; THROMBOCYTE ACTIVATION; THROMBOCYTE FREE PLASMA;

BLOOD PLATELETS; CD40 LIGAND; FEMALE; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; P-SELECTIN; PEPTIDE FRAGMENTS; PLATELET ACTIVATION;

EID: 1642442673     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1399-0012.2003.00137.x     Document Type: Article

References (28)

1. Cooke GE, Eaton GM, Whitby G et al. Plasma atherogenic markers in congestive heart failure and posttransplant (heart) patients. J Am Coll Cardiol 2000: 36: 509.
2. Weis M, Von Scheidt W. Cardiac allograft vasculopathy: A review. Circulation 1997: 96: 2069.
3. Power CA, Clemetson JM, Clemetson KJ, Wells TN. Chemokine and chemokine receptor mRNA expression in human platelets. Cytokine 1995: 7: 479.
4. Gawaz M, Neumann FJ, Dickfeld T et al. Activated platelets induce monocyte chemotactic protein-1 secretion and surface expression of intercellular adhesion molecule-1 on endothelial cells. Circulation 1998: 98: 1164.
5. de Bruijne-Admiraal LG, Modderman PW, von dem Borne AE, Sonnenberg A. P-selectin mediates Ca(2+)-dependent adhesion of activated platelets to many different types of leukocytes: Detection by flow cytometry. Blood 1992: 80: 134.
6. Andreassen AK, Nordoy I, Simonsen S et al. Levels of circulating adhesion molecules in congestive heart failure and after heart transplantation. Am J Cardiol 1998: 81: 604.
7. Holme PA, Muller F, Solum NO, Brosstad F, Froland SS, Aukrust P. Enhanced activation of platelets with abnormal release of RANTES in human immunodeficiency virus type 1 infection. FASEB J 1998: 12: 79.
8. Aukrust P, Muller F, Ueland T et al. Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina. Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes. Circulation 1999: 100: 614.
9. Holm T, Aukrust P, Aagaard E et al. Hypertension in relation to nitric oxide, asymmetric dimethylarginine, and inflammation: Different patterns in heart transplant recipients and individuals with essential hypertension. Transplantation 2002: 74: 1395.
10. Dore M. Platelet-leukocyte interactions. Am Heart J 1998: 135(5 Pt 2 Su): S146.
11. Michelson AD. Flow cytometry: A clinical test of platelet function. Blood 1996: 87: 4925.
12. Lefer AM. Platelets: Unindicted coconspirators in inflammatory tissue injury. Circ Res 2000: 87: 1077.
13. Page CP. Platelets as inflammatory cells. Immunopharmacology 1989: 17: 51.
14. Henn V, Slupsky JR, Grafe M et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 1998: 391: 591.
15. George JN. Platelets. Lancet 2000: 355: 1531.
16. Weyrich AS, Elstad MR, McEver RP et al. Activated platelets signal chemokine synthesis by human monocytes. J Clin Invest 1996: 97: 1525.
17. Damle NK, Klussman K, Dietsch MT, Mohagheghpour N, Aruffo A. GMP-140 (P-selectin/CD62) binds to chronically stimulated but not resting CD4+ T lymphocytes and regulates their production of proinflammatory cytokines. Eur J Immunol 1992: 22: 1789.
18. Holm T, Aukrust P, Andreassen AK et al. Peripheral endothelial dysfunction in heart transplant recipients: Possible role of proinflammatory cytokines. Clin Transplant 2000: 14: 218.
19. Gullestad L, Simonsen S, Ueland T et al. Possible role of proinflammatory cytokines in heart allograft coronary artery disease. Am J Cardiol 1999: 84: 999.
20. Aukrust P, Muller F, Froland SS. Circulating levels of RANTES in human immunodeficiency virus type 1 infection: Effect of potent antiretroviral therapy. J Infect Dis 1998: 177: 1091.
21. Lande K, Os I, Kjeldsen SE et al. Increased platelet size and release reaction in essential hypertension. J Hypertens 1987: 5: 401.
22. Kjeldsen SE, Lande K, Gjesdal K et al. Increased platelet release reaction in 50-year-old men with essential hypertension: correlation with atherogenic cholesterol fractions. Am Heart J 1987: 113: 151.
23. Fateh-Moghadam S, Bocksch W, Ruf A et al. Changes in surface expression of platelet membrane glycoproteins and progression of heart transplant vasculopathy. Circulation 2000: 102: 890.
24. Gurbel PA, Gattis WA, Fuzaylov SF et al. Evaluation of platelets in heart failure: Is platelet activity related to etiology, functional class, or clinical outcomes? Am Heart J 2002: 143: 1068.
25. Serebruany VL, Cummings CC, Malinin AI, Steinhubl SR, Gurbel PA. Uniform platelet activation exists before coronary stent implantation despite aspirin therapy. Am Heart J 2001: 142: 611.
26. Cambria-Kiely JA, Gandhi PJ. Possible mechanisms of aspirin resistance. J Thromb Thrombolysis 2002: 13: 49.
27. de Lorgeril M, Dureau G, Boissonnat P et al. Increased platelet aggregation after heart transplantation: Influence of aspirin. J Heart Lung Transplant 1991: 10: 600.
28. de Lorgeril M, Boissonnat P, Dureau G, Guidollet J, Renaud S. Evaluation of ticlopidine, a novel inhibitor of platelet aggregation, in heart transplant recipients. Transplantation 1993: 55: 1195.